Client News

AL-S Pharma Appoints Internationally Recognized Neurologist and Clinical Trial Expert Prof. Dr. Angela Genge as Chief Medical Officer

Heidelberg Pharma Significantly Reduces Operating Costs and Focuses on Lead ADC Candidate HDP-101 Due to Delayed Milestone Payment

CARBIOS presents its 2025 half-year results and confirms its objective to build a PET biorecycling plant, with a revised timeline

Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting

Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland – Company Provides Update on eAArly DETECT 2 Study

HeartBeat.bio Joins Forces with Boehringer Ingelheim to Advance Gene Therapies for Inherited Heart Muscle Disorders

DEBRA Research and Nonsense Therapeutics Launch ReadOn Therapeutics to Accelerate Novel Therapies for Epidermolysis Bullosa

Mallia to Present sCD83’s Potential for Supporting Hair Transplantation at the FUE Europe Meeting in Madrid

Horus Pharma Becomes Additional Commercialization Partner for Formycon’s Eylea® Biosimilar FYB203 in Selected European Countries under the Brand Name Baiama®

Newron Presents H1 2025 Results and Provides Business Update